Skip to main content
ABIVAX Société Anonyme (EPA:ABVX)
France flag France · Delayed Price · Currency is EUR
95.55
-1.10 (-1.14%)
Apr 28, 2026, 5:35 PM CET

ABIVAX Société Anonyme Revenue

In the year 2025, ABIVAX Société Anonyme had annual revenue of 4.57M EUR, down -63.22%. ABIVAX Société Anonyme had revenue of 1.91M in the quarter ending December 31, 2025, a decrease of -55.37%.

Revenue
4.57M
Revenue Growth
-63.22%
P/S Ratio
1,655.61
Revenue / Employee
66.23K
Employees
69
Market Cap
7.57B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.57M-7.86M-63.22%
Dec 31, 202412.43M7.85M171.67%
Dec 31, 20234.57M69.00K1.53%
Dec 31, 20224.51M302.00K7.19%
Dec 31, 20214.20M4.19M29,921.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nanobiotix 32.59M
DBV Technologies 4.80M
Inventiva 6.76M
MedinCell 32.44M
Genfit 65.43M
Valneva SE 174.66M
Cellectis 67.79M
Transgene 7.21M
Revenue Rankings

ABIVAX Société Anonyme News

More News